EKSO (STOCKS)
Ekso Bionics Holdings, Inc. Common Stock
$9.630000
+0.610000 (+6.76%)
Prev close: $9.020000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Scott G. Davis
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $33.25M
- Employees
- 66
- P/E (TTM)
- -1.78
- P/B (TTM)
- 3.56
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
4
Buy
2
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$-1.33 | $-0.29 | -1.0393 | -357.52% |
|
Sep 2025 (Q3)
|
$-0.54 | $-1.17 | +0.6279 | +53.76% |
|
Jun 2025 (Q2)
|
$-1.24 | $-1.38 | +0.1370 | +9.95% |
|
Mar 2025 (Q1)
|
$-1.80 | $-1.68 | -0.1170 | -6.95% |
Financial Statements
| Revenues | $12.80M |
| Benefits Costs and Expenses | $24.49M |
| Cost Of Revenue | $5.95M |
| Costs And Expenses | $24.49M |
| Gross Profit | $6.85M |
| Nonoperating Income/Loss | $1.63M |
| Operating Expenses | $20.17M |
| Research and Development | $3.03M |
| Other Operating Expenses | $17.14M |
| Operating Income/Loss | -$13.33M |
| Income/Loss From Continuing Operations After Tax | -$11.70M |
| Income/Loss From Continuing Operations Before Tax | -$11.70M |
| Income Tax Expense/Benefit | $0.00 |
| Net Income/Loss | -$11.70M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$11.70M |
| Net Income/Loss Available To Common Stockholders, Basic | -$11.92M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $226.00K |
| Preferred Stock Dividends And Other Adjustments | $226.00K |
| Basic Earnings Per Share | -$4.91 |
| Diluted Earnings Per Share | -$4.91 |
| Basic Average Shares | 2,426,000 |
| Assets | $20.11M |
| Current Assets | $14.05M |
| Inventory | $4.82M |
| Other Current Assets | $9.23M |
| Noncurrent Assets | $6.06M |
| Fixed Assets | $1.29M |
| Intangible Assets | $3.50M |
| Other Non-current Assets | $1.27M |
| Liabilities | $11.08M |
| Current Liabilities | $8.64M |
| Accounts Payable | $1.43M |
| Wages | $1.20M |
| Other Current Liabilities | $6.01M |
| Noncurrent Liabilities | $2.45M |
| Equity | $9.03M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $9.03M |
| Liabilities And Equity | $20.11M |
| Net Cash Flow From Operating Activities | -$11.80M |
| Net Cash Flow From Operating Activities, Continuing | -$11.80M |
| Net Cash Flow From Investing Activities | -$188.00K |
| Net Cash Flow From Investing Activities, Continuing | -$188.00K |
| Net Cash Flow From Financing Activities | $6.63M |
| Net Cash Flow From Financing Activities, Continuing | $6.63M |
| Exchange Gains/Losses | $36.00K |
| Net Cash Flow | -$5.32M |
| Net Cash Flow, Continuing | -$5.36M |
| Comprehensive Income/Loss | -$13.34M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$13.34M |
| Other Comprehensive Income/Loss | -$13.34M |